WallStreetZenWallStreetZen

NASDAQ: NVCT
Nuvectis Pharma Inc Stock Ownership - Who owns Nuvectis Pharma?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Nuvectis Pharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Ron BentsurChairman CEO2024-03-185,000$10.29
$51.45kBuy
Ron BentsurChairman CEO2023-10-10640$11.08
$7.09kBuy
Ron BentsurChairman CEO2023-10-09830$11.19
$9.29kBuy
Ron BentsurChairman CEO2023-10-06250$11.27
$2.82kBuy
Ron BentsurChairman CEO2023-10-051,400$11.09
$15.53kBuy
Ron BentsurChairman CEO2023-10-041,820$10.95
$19.93kBuy
Ron BentsurChairman CEO2023-08-16115$15.15
$1.74kBuy
Ron BentsurChairman CEO2023-08-15235$14.34
$3.37kBuy
Ron BentsurChairman CEO2023-08-11180$14.66
$2.64kBuy
Ron BentsurChairman CEO2023-08-08120$14.83
$1.78kBuy

1 of 5

NVCT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVCT insiders and whales buy or sell their stock.

NVCT Shareholders

What type of owners hold Nuvectis Pharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ron Bentsur18.25%3,242,484$21.79MInsider
Marlio Charles Mosseri14.60%2,595,000$17.44MInsider
Enrique Poradosu8.46%1,503,819$10.11MInsider
Shay Shemesh8.40%1,491,955$10.03MInsider
Blackrock Inc2.18%387,891$2.61MInstitution
Vanguard Group Inc1.66%294,283$1.98MInstitution
Baldwin Brothers LLC0.80%142,040$954.51kInstitution
Geode Capital Management LLC0.74%131,657$884.74kInstitution
State Street Corp0.67%118,279$794.83kInstitution
Kenneth Hoberman0.41%73,140$491.50kInsider

1 of 3

NVCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVCT8.52%50.88%Net BuyingNet Buying
RLMD45.13%3.43%Net BuyingNet Buying
SYRS46.94%53.06%Net BuyingNet Selling
CTXR16.86%7.74%
GLYC35.53%64.47%Net BuyingNet Buying
View Top Biotech Stocks

Nuvectis Pharma Stock Ownership FAQ

Who owns Nuvectis Pharma?

Nuvectis Pharma (NASDAQ: NVCT) is owned by 8.52% institutional shareholders, 50.88% Nuvectis Pharma insiders, and 40.60% retail investors. Ron Bentsur is the largest individual Nuvectis Pharma shareholder, owning 3.24M shares representing 18.25% of the company. Ron Bentsur's Nuvectis Pharma shares are currently valued at $22.11M.

If you're new to stock investing, here's how to buy Nuvectis Pharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.